MCT2D Clinician Decision Aid: SGLT-2 Inhibitor / GLP-1 RA for Type 2 Diabetes
Updated: 10/16/23
SGLT2 inhibitors and GLP-1 receptor agonists are first-line treatments for T2D in patients with cardiorenal disease. This aid is meant to be used alongside your own clinical judgment, guideline-directed therapy, and prescribing information to guide individualization of diabetes treatment.
Lead clinical author is Heidi Diez, PharmD, clinical pharmacist, with Michael Heung, MD, nephrologist.
Tags: For Providers, Point-of-care, Created By MCT2D